| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/09/2003 | EP1299376A1 Fatty acid synthase inhibitors |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299372A1 Pyrones as inhibitors of cyclooxygenase-2 |
| 04/09/2003 | EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 04/09/2003 | EP1299363A1 Polymorphic forms/hydrates of n- 4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 04/09/2003 | EP1299361A1 Pyrazole derivatives |
| 04/09/2003 | EP1299360A2 Heterocycle carboxamides as antiviral agents |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1299356A1 Novel compounds |
| 04/09/2003 | EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/09/2003 | EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/09/2003 | EP1299352A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 04/09/2003 | EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 04/09/2003 | EP1299349A2 Compounds to treat alzheimer's disease |
| 04/09/2003 | EP1299128A2 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 04/09/2003 | EP1299125A1 Production, stabilisation and use of reduced forms of pharmaceutical compounds |
| 04/09/2003 | EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 04/09/2003 | EP1299121A2 Thromboxane receptor antagonist containing formulations for potentiating organic nitrates having vasodilating activity |
| 04/09/2003 | EP1299119A2 Immunosuppressive compositions comprising an immunophilin-binding compound and a ginkgolide compound |
| 04/09/2003 | EP1299104A1 Tamper-resistant oral opioid agonist formulations |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299101A1 Carvedilol |
| 04/09/2003 | EP1299097A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol |
| 04/09/2003 | EP1299096A1 Prostaglandin compounds for treating congestive heart failure |
| 04/09/2003 | EP1299092A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 04/09/2003 | EP1299091A2 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 04/09/2003 | EP1299089A2 Drug delivery system for poorly water soluble drugs |
| 04/09/2003 | EP1299032A1 DNA encoding human serine protease D-G |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1149101B1 4-OXO-3,5-DIHYDRO-4$i(H)-PYRIDAZINO 4,5-$i(b)]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE |
| 04/09/2003 | EP1140055B1 Use of a 5ht 2a? and 5ht 2a/c? receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways |
| 04/09/2003 | EP1094824A4 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| 04/09/2003 | EP1091950B1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 04/09/2003 | EP1082116B1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders |
| 04/09/2003 | EP1017681B1 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 04/09/2003 | EP1001766B1 Compounds for the treatment of ccr5-mediated diseases |
| 04/09/2003 | EP0998494B1 Pompilid wasp-derived neuropeptides |
| 04/09/2003 | EP0996612B1 Aliphatic propargylamines as cellular rescue agents |
| 04/09/2003 | EP0993458B1 3-benzylpiperidine |
| 04/09/2003 | EP0993301B1 Cocaine receptor binding ligands |
| 04/09/2003 | EP0973531B1 Facilitation of wound healing with cm101/gbs toxin |
| 04/09/2003 | EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 04/09/2003 | EP0946165B1 Integrin antagonists |
| 04/09/2003 | EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists |
| 04/09/2003 | EP0915875B1 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| 04/09/2003 | EP0912191B1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 04/09/2003 | EP0902684B1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 04/09/2003 | EP0874808B1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 04/09/2003 | EP0873123B1 Inhibitors of protein isoprenyl transferases |
| 04/09/2003 | EP0831726B1 Health food product |
| 04/09/2003 | EP0804552B1 Redirection of cellular immunity by receptor chimeras |
| 04/09/2003 | EP0793492B1 Use of sclareolide for treating disorders characterised by excessive cell proliferation |
| 04/09/2003 | EP0756483B1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis |
| 04/09/2003 | EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect |
| 04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409767A Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/09/2003 | CN1409765A Prevention of myocarditis, abortion and intrauterine infection associated with procine circovirus 2 |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1409720A Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 04/09/2003 | CN1409716A New amino propylphosphinic acid |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409712A Pyrrolo [2,3-d] pyrimidine compounds |
| 04/09/2003 | CN1409711A Fused naphthalene dinitrogen compound useful as HIV reverse transcriptase inhibitors |
| 04/09/2003 | CN1409709A Substituted bisindolylmaleimides for inhibition of cell proliferation |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409633A Combinations of(S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxion[2,3-e]indol-8-one and neuroleptics |
| 04/09/2003 | CN1409629A Agents for promoting fattening of animals and method of promoting fattening |
| 04/09/2003 | CN1409605A Method for increasing pet activity |
| 04/09/2003 | CN1408881A Synaptic knob association membrane protein 25 and its use |
| 04/09/2003 | CN1408703A New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method |
| 04/09/2003 | CN1408408A Snoring stopping health pill |
| 04/09/2003 | CN1408397A Composition containing melatonin and galangal fruit traditional Chinese medicine |
| 04/09/2003 | CN1408390A Pure traditional Chinese medicine preparation for curing chronic effort syndrome and its preparing method |
| 04/09/2003 | CN1408385A Medicine for curing summer heat wetness cold and preparing method |
| 04/09/2003 | CN1408373A Medicine for resisting senility, shrinking vagina, beautifying breast and stregthening male genitals and its production method |
| 04/09/2003 | CN1408360A Use of algin oligosaccharide in anti-senility and anti-dementia |
| 04/09/2003 | CN1105116C Thienopyrimidine with PDE V-inhibiting effect |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105112C Benzothiophenecarboxamide derivatives and PGD2 antagonist comprising them |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104897C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor |
| 04/09/2003 | CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor |
| 04/09/2003 | CN1104894C Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/09/2003 | CN1104845C Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed |
| 04/08/2003 | WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 04/08/2003 | US6545182 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/08/2003 | US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins |
| 04/08/2003 | US6545127 Catalytically active recombinant memapsin and methods of use thereof |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc. |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545041 Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |